Guido J. Neels - 01 Jun 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/Guido Neels
Issuer symbol
AXGN
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
03 Jun 2021, 17:12:49 UTC
Previous filing
07 Jun 2021
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $0 +6,173 +14% $0.000000 48,764 01 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Options Exercise $0 -6,173 -100% $0.000000* 0 01 Jun 2021 Common Stock 6,173 Direct F1, F2
transaction AXGN Stock Option (right to purchase) Award $0 +6,030 $0.000000 6,030 01 Jun 2021 Common Stock 6,030 $19.76 Direct F3
transaction AXGN Restricted Stock Units Award $0 +3,036 $0.000000 3,036 01 Jun 2021 Common Stock 3,036 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2 This reflects the number of restricted stock units that became vested as of June 1, 2021.
F3 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.